Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Torii Pharmaceutical Co. Ltd.
Industry Sector: HealthTechnology
CEO: Goichi Matsuda
Number Of Employees: N/A
Enterprise Value: $574,247,194
PE Ratio: 25.28
Exchange/Ticker 1: Tokyo:4551
Exchange/Ticker 2: N/A
Latest Market Cap: $857,383,072
BioCentury | Oct 19, 2024
Finance
Biotech restructurings show signs of slowing
Temporary respite or reflection of a stabilizing sector?
BioCentury | Jun 30, 2023
Regulation
Six PDUFA dates on FDA’s July calendar
Decisions due next month include full approval of Leqembi for Alzheimer’s and quizartinib for AML
BioCentury | Jan 22, 2021
Regulation
CAR T Yescarta among new approvals by Japanese regulator
Yescarta became the second approved CAR T therapy in Japan, joining a basket of new approvals by the country’s Ministry of Health, Labour and Welfare. The therapy, developed by Gilead Sciences
BioCentury | Nov 6, 2019
Company News
Nov. 5 Company Quick Takes: Takeda licenses MD Anderson CAR NK cell portfolio; plus Myriad, Canbridge, BioCryst-Torii and Strongbridge
Items per page:
1 - 10 of 74